alexa Abstract | Hypercoagulability Due to Protein S Deficiency in HIV-Seropositive Patients

International Journal of Collaborative Research on Internal Medicine & Public Health
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Abstract

Background: Thrombosis due to a hypercoagulable state is a serious clinical problem in HIV-infected individuals that can lead to life-threatening thromboembolic phenomenon.

Objective: To describe the salient clinical features of dual HIV infection and protein S deficiency.

Design: Retrospective case series.

Subjects: HIV seropositive patients with laboratory-confirmed protein S deficiency.

Results: Three patients had concurrent protein C deficiency. No patient had other primary or secondary risk factors for thrombophilia. Seven subjects had symptomatic thromboembolic manifestations that included deep venous thrombosis (5 subjects), pulmonary embolism (4 subjects), inferior vena cava thrombosis (2 subject), and/or stroke (1 subject). Five additional patients were identified with asymptomatic protein S deficiency. All subjects were African-American.; the mean patient age was 44 years (range, 21 to 60 years). The mean CD4+ cell count was 102 per mm3 (range 0-343), and the mean HIV RNA level was 71,772 copies/mL (range 1,421-554,237 copies/mL). Only three patients were receiving highly active antiretroviral therapy (HAART) at the time of clinical presentation. All symptomatic subjects received heparin, with or without warfarin, for their thromboembolic event and all but one recovered.

Conclusion: HIV-infected patients should be screened for acquired protein S deficiency, which contributes to hypercoagulability and risk of clinical thromboembolic events. Asymptomatic patients with reduced plasma free protein S levels may benefit from aspirin primary prophylaxis.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Dragana Orlovic Raymond A Smego

Keywords

Protein S deficiency, Hypercoagulable, Thromboembolic, HIV/AIDS

 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords